CIBC Private Wealth Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$261K Buy
6,195
+5,309
+599% +$214K ﹤0.01% 1075
2025
Q3
$30.4K Sell
886
-15
-2% -$430 ﹤0.01% 2004
2025
Q2
$24.4K Sell
901
-85
-9% -$2.46K ﹤0.01% 1944
2025
Q1
$28.5K Buy
986
+50
+5% +$1.91K ﹤0.01% 1854
2024
Q4
$41K Sell
936
-25
-3% -$947 ﹤0.01% 1754
2024
Q3
$32.7K Buy
961
+286
+42% +$8.05K ﹤0.01% 1935
2024
Q2
$14.6K Sell
675
-288
-30% -$6.05K ﹤0.01% 2155
2024
Q1
$20.8K Buy
+963
New +$23.5K ﹤0.01% 2027

Other funds holding VCYT

CIBC Private Wealth Group's VCYT Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Veracyte (VCYT) stake by 599% in Q4 2025, buying an estimated $214K and bringing the position to 6,195 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1075.

CIBC Private Wealth Group first reported a position in VCYT in Q1 2024 and has held it in 8 quarters since. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • CIBC Private Wealth Group held 6,195 shares of Veracyte worth $261K as of Q4 2025.
  • CIBC Private Wealth Group bought 5,309 Veracyte shares in Q4 2025, an estimated $214K.
  • Veracyte made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1075 holding.
  • CIBC Private Wealth Group first reported a position in Veracyte in Q1 2024 and has held it in 8 quarters since.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.